Alcamena
Alcamena is dedicated to advancing protein optimization and development through its proprietary directed evolution platform. By leveraging the principles of Darwinian evolution, Alcamena compresses millions of years of evolution into weeks, creating proteins with superior binding affinity and enzymatic activity. The company excels in directed evolution, construct design, library construction, and custom screening techniques, offering solutions that exceed traditional antibody binding affinities and approach the tissue permeability of small molecules. Alcamena's innovations have been validated through collaborations with academic institutions and NIH-funded projects.
Alcamena
1450 South Rolling Road, Suite 4.069, Halethorpe, MD 21227
What We Do
Development of novel proteins with potent enzymatic activity and high binding affinity using a proprietary directed evolution approach.
Generation of large custom peptide libraries and tailored screening methods to identify optimized proteins.
Development of ligands for projects with defined targets using large peptide libraries and directed evolution.
Project management by a Project Director who provides regular updates and designs protein and peptide libraries.